CymaBay Therapeutics, Inc.
CBAYDelisted Mar 22, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001042074
CymaBay Therapeutics, Inc. was delisted on Mar 22, 2024; its insiders filed their last Form 4 on Mar 22, 2024; 200 institutions reported holding it in 13F filings for Q4 2023, worth $2.71B in total; no superinvestor held it.
Q2 2021 vs. Q1 2021
How the institutions holding CymaBay Therapeutics, Inc. changed between Q1 2021 and Q2 2021.
All holders in Q2 2021All holders in Q1 2021
| Measure | Q1 2021 | Q2 2021 | Change |
|---|---|---|---|
| Holders | 130 | 113 | −17 |
| Shares | 55.4M | 52.2M | −3.28M (−5.9%) |
| Value | $251.7M | $227.4M | −$24.3M (−9.6%) |
New holders (12)
Institutions that held CymaBay Therapeutics, Inc. at the end of Q2 2021 but not at the end of Q1 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Kestra Private Wealth Services, LLC | 501,000 | $2.18M | 0.13% |
| Norges Bank | 463,124 | $2.02M | 0.00% |
| Commonwealth Equity Services, LLC | 113,394 | $494.0K | 0.00% |
| Rockefeller Capital Management L.P. | 99,000 | $431.0K | 0.00% |
| Exane Derivatives | 34,214 | $146.1K | 0.03% |
| Raymond James Financial Services Advisors, Inc. | 15,920 | $69.0K | 0.00% |
| Schonfeld Strategic Advisors LLC | 15,003 | $65.0K | 0.00% |
| Vectors Research Management, LLC | 5,000 | $22.0K | 0.01% |
| Point72 Hong Kong Ltd | 1,626 | $7.00K | 0.00% |
| Cowen and Company, LLC | 523 | $2.00K | 0.00% |
| Quadrant Capital Group LLC | 107 | $0 | 0.00% |
| Steward Partners Investment Advisory, LLC | 1 | $0 | 0.00% |
Sold out (29)
Institutions that held CymaBay Therapeutics, Inc. at the end of Q1 2021 and filed for Q2 2021 without it.